Kineret (anakinra), a new biotech drug for rheumatoid arthritis

July 2002

Amgen is now marketing Kineret (anakinra), a new biotech drug for rheumatoid arthritis.

It's the first interleukin-1 (IL-1) receptor antagonist.

Blocking this protein reduces joint pain and inflammation...and might slow the progression of the disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

how to treat persistent pain in the elderly
Cholesterol statins might cause peripheral neuropathy
Ophthalmology new prostaglandin eyedrop for glaucoma called Lumigan (bimatoprost)
Women's Health Should women stop taking oral contraceptives before surgery?
Women's Health Zoloft (sertraline) or Prozac (fluoxetine) for premenstrual dysphoric disorder (PMDD)
Kineret (anakinra), a new biotech drug for rheumatoid arthritis
Infectious Diseases Summer travellers are asking about international precautions
Infectious Diseases reintroducing the IV antifungal Cancidas
Infectious Diseases Vfend (voriconazole), a new antifungal
Diabetes when it's appropriate to use "alternate site testing" for measuring blood glucose
angiotensin receptor blockers (ARBs) might help prevent headaches
hyponatremia in patients taking SSRIs (fluoxetine, etc) or venlafaxine (Effexor)
Hematology & Oncology Celebrex (celecoxib) is now approved for a hereditary form of colorectal cancer
Natural Medicines Nexrutine, an herbal ingredient being called a "natural COX-2 inhibitor."
Natural Medicines astaxanthin (as-ta-ZAN-thin), an antioxidant that's popping up in many products
Men's Health men getting BOTH Proscar and an alpha-blocker for benign prostatic hyperplasia